BusinessPetLife Pharmaceuticals’ CEO Dr. Salvagno Provides White Paper on “Venenotherapy” While Preparing for FDA SubmissionBy Nasdaq OMXDec 6, 2016, 1:01 PM UTC
BusinessPetLife Pharmaceuticals’ CEO Dr. Salvagno Provides White Paper on “Venenotherapy” While Preparing for FDA SubmissionBy Nasdaq OMXDec 6, 2016, 1:01 PM UTC